Cellular Metabolism:
Acts as an essential coenzyme that helps cells process nutrients and carry out metabolic reactions.
$299.00 $200.00/mo, 2 month supply 1 vial
A prescription NAD+ injection designed to support cellular energy metabolism, mitochondrial function, and healthy cellular processes.
Supports cellular energy metabolism: NAD+ helps cells convert nutrients into pathways used to produce cellular energy.
Supports mitochondrial function: NAD+/NADH cycling plays an essential role in mitochondrial ATP production.
Supports cellular redox balance: NAD+ participates in oxidation-reduction reactions fundamental to healthy cellular metabolism.
Supports cellular maintenance pathways: NAD+ is utilized by enzymes involved in cellular signaling, stress responses, and DNA-related processes.
Administration: NAD+ may cause flushing, and the supplied protocol recommends slow administration. Follow the administration instructions provided by your prescribing clinician and dispensing pharmacy.
Injection-site reactions: Subcutaneous administration may cause temporary redness, tenderness, swelling, burning, bruising, or localized irritation.
Cardiovascular symptoms: Patients with cardiovascular conditions should discuss treatment with their clinician. Significant palpitations, chest discomfort, shortness of breath, fainting, or other concerning symptoms warrant appropriate medical evaluation.
Pregnancy & breastfeeding: Safety data for supplemental injectable NAD+ during pregnancy and breastfeeding are limited. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss treatment with their clinician.
Persistent fatigue: Significant or persistent fatigue should not automatically be attributed to low NAD+. Other underlying causes may require evaluation.
Potential side effects may include:
Individual response and tolerability may vary.
NAD+ is a naturally occurring coenzyme involved in cellular energy metabolism, mitochondrial function, redox balance, and cellular signaling. It helps transfer electrons during metabolic reactions and supports several essential cellular processes.
NAD+ is essential to the pathways cells use to generate energy. It helps transfer energy from nutrients into mitochondrial pathways involved in ATP production. However, NAD+ is not a stimulant and does not directly provide energy.
During metabolism, NAD+ accepts electrons and becomes NADH. NADH then transfers electrons into the mitochondrial electron transport chain, contributing to the process mitochondria use to produce ATP.
NAD+ participates in cellular energy metabolism, which is why it may be incorporated into clinician-directed wellness protocols focused on energy and fatigue. However, clinical evidence that injectable NAD+ specifically treats fatigue remains limited, and fatigue can have many underlying causes.
NAD+ is fundamental to neuronal energy metabolism and is being studied in relation to brain health and cognitive aging. However, injectable NAD+ has not been established as an FDA-approved treatment for cognitive impairment or neurodegenerative disease.
NAD+ metabolism is closely connected to cellular pathways studied in aging research, including mitochondrial function, sirtuin activity, DNA-related processes, and metabolic regulation. However, NAD+ injections have not been proven to extend human lifespan or reverse aging.
This formulation provides NAD+ through subcutaneous administration. The appropriate route and formulation should be determined by your prescribing clinician, and injectable NAD+ should not automatically be considered superior to oral NAD+-related supplements.
No. This compounded NAD+ Injectable formulation is not FDA-approved. Injectable NAD+ for mitochondrial support, cognitive wellness, fatigue, or healthy-aging purposes has not undergone FDA premarket review for these uses.
NAD+ Injectable is a compounded injectable formulation containing 100 mg/mL of nicotinamide adenine dinucleotide (NAD+), a naturally occurring coenzyme found throughout the body.
NAD+ plays an essential role in cellular energy metabolism, mitochondrial function, redox reactions, and cellular signaling. It also serves as a substrate for enzymes involved in cellular maintenance and stress-response pathways.
This compounded NAD+ Injectable formulation is not FDA-approved.
Acts as an essential coenzyme that helps cells process nutrients and carry out metabolic reactions.
Transfers electrons through its NADH form to support mitochondrial ATP production, the body’s primary source of cellular energy.
Participates in enzyme pathways involved in cellular communication, metabolism, and stress responses.
Serves as a key component in enzyme processes involved in DNA repair and normal cellular maintenance.
These uses are investigational and should be distinguished from FDA-approved indications. Injectable NAD+ is not FDA-approved for improving energy, treating fatigue, enhancing cognition, or extending lifespan.
All dosing should follow the instructions provided by the prescribing clinician.
NAD+ Injectable contains nicotinamide adenine dinucleotide (NAD+), an essential cellular coenzyme involved in redox reactions that help convert nutrients into usable energy within the mitochondria. NAD+ also serves as a substrate for enzymes including sirtuins and PARPs, which participate in metabolic signaling, cellular stress responses, DNA repair, and mitochondrial function. Because NAD+ availability is closely linked to cellular energy metabolism and may decline with age and metabolic stress, NAD+ pathways are an active area of research in cellular resilience, mitochondrial health, and healthy aging.
